 | • レポートコード：D0GIR-00415 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、分子血の世界市場を広く調査・分析し、今後の市場展望をまとめております。分子血の種類別市場規模（PCR、PCR-RFLP、AS-PCR・PCR-SSP、マルチプレックスPCR、リアルタイムPCR、サンガーDNAシーケンス、パイロシーケンス）、用途別市場規模（血液センター、血漿分画施設、病院、民間・民間研究所、軍事血液銀行）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Danaher、Hologic、QIAGEN、Becton, Dickinson、Roche Diagnostics、Cepheid、Siemens Healthcare、Grifols、Biomerieux ・地域別グローバル市場分析 2015年-2020年 ・分子血の北米市場（アメリカ、カナダ、メキシコ） ・分子血のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・分子血のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・分子血の南米市場（ブラジル、アルゼンチン） ・分子血の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：PCR、PCR-RFLP、AS-PCR・PCR-SSP、マルチプレックスPCR、リアルタイムPCR、サンガーDNAシーケンス、パイロシーケンス ・用途別分析：血液センター、血漿分画施設、病院、民間・民間研究所、軍事血液銀行 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Molecular Blood market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Molecular Blood market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Molecular Blood market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Molecular Blood market has been segmented into:
PCR
PCR-RFLP
AS-PCR or PCR-SSP
Multiplex PCR
Real Time PCR
Sanger DNA Sequencing
Pyrosequencing
By Application, Molecular Blood has been segmented into:
Blood Centers
Plasma Fractionation Facilities
Hospitals
Commercial/Private Laboratories
Military Blood Banks
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Molecular Blood market presented in the report. This section sheds light on the sales growth of different regional and country-level Molecular Blood markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Molecular Blood market.
The report offers in-depth assessment of the growth and other aspects of the Molecular Blood market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Molecular Blood Market Share Analysis
Molecular Blood competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Molecular Blood sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Molecular Blood sales, revenue and market share for each player covered in this report.
The major players covered in Molecular Blood are:
Abbott Laboratories
Danaher
Hologic
QIAGEN
Becton, Dickinson
Roche Diagnostics
Cepheid
Siemens Healthcare
Grifols
Biomerieux
Table of Contents
1 Molecular Blood Market Overview
1.1 Product Overview and Scope of Molecular Blood
1.2 Classification of Molecular Blood by Type
1.2.1 Global Molecular Blood Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Molecular Blood Revenue Market Share by Type in 2019
1.2.3 PCR
1.2.4 PCR-RFLP
1.2.5 AS-PCR or PCR-SSP
1.2.6 Multiplex PCR
1.2.7 Real Time PCR
1.2.8 Sanger DNA Sequencing
1.2.9 Pyrosequencing
1.3 Global Molecular Blood Market by Application
1.3.1 Overview: Global Molecular Blood Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Blood Centers
1.3.3 Plasma Fractionation Facilities
1.3.4 Hospitals
1.3.5 Commercial/Private Laboratories
1.3.6 Military Blood Banks
1.4 Global Molecular Blood Market by Regions
1.4.1 Global Molecular Blood Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Molecular Blood (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Molecular Blood Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Molecular Blood Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Blood Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Molecular Blood Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Blood Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Molecular Blood Revenue, Gross Margin and Market Share (2018-2019)
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Danaher SWOT Analysis
2.2.4 Danaher Product and Services
2.2.5 Danaher Molecular Blood Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hologic
2.3.1 Hologic Details
2.3.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hologic SWOT Analysis
2.3.4 Hologic Product and Services
2.3.5 Hologic Molecular Blood Revenue, Gross Margin and Market Share (2018-2019)
2.4 QIAGEN
2.4.1 QIAGEN Details
2.4.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 QIAGEN SWOT Analysis
2.4.4 QIAGEN Product and Services
2.4.5 QIAGEN Molecular Blood Revenue, Gross Margin and Market Share (2018-2019)
2.5 Becton, Dickinson
2.5.1 Becton, Dickinson Details
2.5.2 Becton, Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Becton, Dickinson SWOT Analysis
2.5.4 Becton, Dickinson Product and Services
2.5.5 Becton, Dickinson Molecular Blood Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche Diagnostics
2.6.1 Roche Diagnostics Details
2.6.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche Diagnostics SWOT Analysis
2.6.4 Roche Diagnostics Product and Services
2.6.5 Roche Diagnostics Molecular Blood Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cepheid
2.7.1 Cepheid Details
2.7.2 Cepheid Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cepheid SWOT Analysis
2.7.4 Cepheid Product and Services
2.7.5 Cepheid Molecular Blood Revenue, Gross Margin and Market Share (2018-2019)
2.8 Siemens Healthcare
2.8.1 Siemens Healthcare Details
2.8.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Siemens Healthcare SWOT Analysis
2.8.4 Siemens Healthcare Product and Services
2.8.5 Siemens Healthcare Molecular Blood Revenue, Gross Margin and Market Share (2018-2019)
2.9 Grifols
2.9.1 Grifols Details
2.9.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Grifols SWOT Analysis
2.9.4 Grifols Product and Services
2.9.5 Grifols Molecular Blood Revenue, Gross Margin and Market Share (2018-2019)
2.10 Biomerieux
2.10.1 Biomerieux Details
2.10.2 Biomerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Biomerieux SWOT Analysis
2.10.4 Biomerieux Product and Services
2.10.5 Biomerieux Molecular Blood Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Molecular Blood Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Molecular Blood Players Market Share
3.2.2 Top 10 Molecular Blood Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Molecular Blood Revenue and Market Share by Regions
4.2 North America Molecular Blood Revenue and Growth Rate (2015-2020)
4.3 Europe Molecular Blood Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Molecular Blood Revenue and Growth Rate (2015-2020)
4.5 South America Molecular Blood Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Molecular Blood Revenue and Growth Rate (2015-2020)
5 North America Molecular Blood Revenue by Countries
5.1 North America Molecular Blood Revenue by Countries (2015-2020)
5.2 USA Molecular Blood Revenue and Growth Rate (2015-2020)
5.3 Canada Molecular Blood Revenue and Growth Rate (2015-2020)
5.4 Mexico Molecular Blood Revenue and Growth Rate (2015-2020)
6 Europe Molecular Blood Revenue by Countries
6.1 Europe Molecular Blood Revenue by Countries (2015-2020)
6.2 Germany Molecular Blood Revenue and Growth Rate (2015-2020)
6.3 UK Molecular Blood Revenue and Growth Rate (2015-2020)
6.4 France Molecular Blood Revenue and Growth Rate (2015-2020)
6.5 Russia Molecular Blood Revenue and Growth Rate (2015-2020)
6.6 Italy Molecular Blood Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Molecular Blood Revenue by Countries
7.1 Asia-Pacific Molecular Blood Revenue by Countries (2015-2020)
7.2 China Molecular Blood Revenue and Growth Rate (2015-2020)
7.3 Japan Molecular Blood Revenue and Growth Rate (2015-2020)
7.4 Korea Molecular Blood Revenue and Growth Rate (2015-2020)
7.5 India Molecular Blood Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Molecular Blood Revenue and Growth Rate (2015-2020)
8 South America Molecular Blood Revenue by Countries
8.1 South America Molecular Blood Revenue by Countries (2015-2020)
8.2 Brazil Molecular Blood Revenue and Growth Rate (2015-2020)
8.3 Argentina Molecular Blood Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Molecular Blood by Countries
9.1 Middle East & Africa Molecular Blood Revenue by Countries (2015-2020)
9.2 Saudi Arabia Molecular Blood Revenue and Growth Rate (2015-2020)
9.3 UAE Molecular Blood Revenue and Growth Rate (2015-2020)
9.4 Egypt Molecular Blood Revenue and Growth Rate (2015-2020)
9.5 South Africa Molecular Blood Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Molecular Blood Revenue and Market Share by Type (2015-2020)
10.2 Global Molecular Blood Market Forecast by Type (2019-2024)
10.3 PCR Revenue Growth Rate (2015-2025)
10.4 PCR-RFLP Revenue Growth Rate (2015-2025)
10.5 AS-PCR or PCR-SSP Revenue Growth Rate (2015-2025)
10.6 Multiplex PCR Revenue Growth Rate (2015-2025)
10.7 Real Time PCR Revenue Growth Rate (2015-2025)
10.8 Sanger DNA Sequencing Revenue Growth Rate (2015-2025)
10.9 Pyrosequencing Revenue Growth Rate (2015-2025)
11 Global Molecular Blood Market Segment by Application
11.1 Global Molecular Blood Revenue Market Share by Application (2015-2020)
11.2 Molecular Blood Market Forecast by Application (2019-2024)
11.3 Blood Centers Revenue Growth (2015-2020)
11.4 Plasma Fractionation Facilities Revenue Growth (2015-2020)
11.5 Hospitals Revenue Growth (2015-2020)
11.6 Commercial/Private Laboratories Revenue Growth (2015-2020)
11.7 Military Blood Banks Revenue Growth (2015-2020)
12 Global Molecular Blood Market Size Forecast (2021-2025)
12.1 Global Molecular Blood Market Size Forecast (2021-2025)
12.2 Global Molecular Blood Market Forecast by Regions (2021-2025)
12.3 North America Molecular Blood Revenue Market Forecast (2021-2025)
12.4 Europe Molecular Blood Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Molecular Blood Revenue Market Forecast (2021-2025)
12.6 South America Molecular Blood Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Molecular Blood Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Molecular Blood Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Molecular Blood by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Molecular Blood Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Molecular Blood Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Molecular Blood Major Business
Table 7. Abbott Laboratories Molecular Blood Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Molecular Blood Product and Solutions
Table 10. Abbott Laboratories Molecular Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Danaher Corporate Information, Location and Competitors
Table 12. Danaher Molecular Blood Major Business
Table 13. Danaher Molecular Blood Total Revenue (USD Million) (2018-2019)
Table 14. Danaher SWOT Analysis
Table 15. Danaher Molecular Blood Product and Solutions
Table 16. Danaher Molecular Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Hologic Corporate Information, Location and Competitors
Table 18. Hologic Molecular Blood Major Business
Table 19. Hologic Molecular Blood Total Revenue (USD Million) (2017-2018)
Table 20. Hologic SWOT Analysis
Table 21. Hologic Molecular Blood Product and Solutions
Table 22. Hologic Molecular Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. QIAGEN Corporate Information, Location and Competitors
Table 24. QIAGEN Molecular Blood Major Business
Table 25. QIAGEN Molecular Blood Total Revenue (USD Million) (2017-2018)
Table 26. QIAGEN SWOT Analysis
Table 27. QIAGEN Molecular Blood Product and Solutions
Table 28. QIAGEN Molecular Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Becton, Dickinson Corporate Information, Location and Competitors
Table 30. Becton, Dickinson Molecular Blood Major Business
Table 31. Becton, Dickinson Molecular Blood Total Revenue (USD Million) (2017-2018)
Table 32. Becton, Dickinson SWOT Analysis
Table 33. Becton, Dickinson Molecular Blood Product and Solutions
Table 34. Becton, Dickinson Molecular Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Roche Diagnostics Corporate Information, Location and Competitors
Table 36. Roche Diagnostics Molecular Blood Major Business
Table 37. Roche Diagnostics Molecular Blood Total Revenue (USD Million) (2017-2018)
Table 38. Roche Diagnostics SWOT Analysis
Table 39. Roche Diagnostics Molecular Blood Product and Solutions
Table 40. Roche Diagnostics Molecular Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Cepheid Corporate Information, Location and Competitors
Table 42. Cepheid Molecular Blood Major Business
Table 43. Cepheid Molecular Blood Total Revenue (USD Million) (2017-2018)
Table 44. Cepheid SWOT Analysis
Table 45. Cepheid Molecular Blood Product and Solutions
Table 46. Cepheid Molecular Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Siemens Healthcare Corporate Information, Location and Competitors
Table 48. Siemens Healthcare Molecular Blood Major Business
Table 49. Siemens Healthcare Molecular Blood Total Revenue (USD Million) (2017-2018)
Table 50. Siemens Healthcare SWOT Analysis
Table 51. Siemens Healthcare Molecular Blood Product and Solutions
Table 52. Siemens Healthcare Molecular Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Grifols Corporate Information, Location and Competitors
Table 54. Grifols Molecular Blood Major Business
Table 55. Grifols Molecular Blood Total Revenue (USD Million) (2017-2018)
Table 56. Grifols SWOT Analysis
Table 57. Grifols Molecular Blood Product and Solutions
Table 58. Grifols Molecular Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Biomerieux Corporate Information, Location and Competitors
Table 60. Biomerieux Molecular Blood Major Business
Table 61. Biomerieux Molecular Blood Total Revenue (USD Million) (2017-2018)
Table 62. Biomerieux SWOT Analysis
Table 63. Biomerieux Molecular Blood Product and Solutions
Table 64. Biomerieux Molecular Blood Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Molecular Blood Revenue (Million USD) by Players (2015-2020)
Table 66. Global Molecular Blood Revenue Share by Players (2015-2020)
Table 67. Global Molecular Blood Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Molecular Blood Revenue Market Share by Regions (2015-2020)
Table 69. North America Molecular Blood Revenue by Countries (2015-2020)
Table 70. North America Molecular Blood Revenue Market Share by Countries (2015-2020)
Table 71. Europe Molecular Blood Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Molecular Blood Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Molecular Blood Revenue by Countries (2015-2020)
Table 74. South America Molecular Blood Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Molecular Blood Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Molecular Blood Revenue Market Share by Countries (2015-2020)
Table 77. Global Molecular Blood Revenue (Million USD) by Type (2015-2020)
Table 78. Global Molecular Blood Revenue Share by Type (2015-2020)
Table 79. Global Molecular Blood Revenue Forecast by Type (2021-2025)
Table 80. Global Molecular Blood Revenue by Application (2015-2020)
Table 81. Global Molecular Blood Revenue Share by Application (2015-2020)
Table 82. Global Molecular Blood Revenue Forecast by Application (2021-2025)
Table 83. Global Molecular Blood Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Molecular Blood Picture
Figure 2. Global Molecular Blood Revenue Market Share by Type in 2019
Figure 3. PCR Picture
Figure 4. PCR-RFLP Picture
Figure 5. AS-PCR or PCR-SSP Picture
Figure 6. Multiplex PCR Picture
Figure 7. Real Time PCR Picture
Figure 8. Sanger DNA Sequencing Picture
Figure 9. Pyrosequencing Picture
Figure 10. Molecular Blood Revenue Market Share by Application in 2019
Figure 11. Blood Centers Picture
Figure 12. Plasma Fractionation Facilities Picture
Figure 13. Hospitals Picture
Figure 14. Commercial/Private Laboratories Picture
Figure 15. Military Blood Banks Picture
Figure 16. Global Molecular Blood Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Molecular Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Molecular Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Molecular Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Molecular Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Molecular Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Molecular Blood Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Molecular Blood Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Molecular Blood Revenue Market Share in 2019
Figure 25. Global Top 10 Players Molecular Blood Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Molecular Blood Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Molecular Blood Revenue Market Share by Regions (2015-2020)
Figure 29. Global Molecular Blood Revenue Market Share by Regions in 2018
Figure 30. North America Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 31. Europe Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 33. South America Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 35. North America Molecular Blood Revenue Market Share by Countries (2015-2020)
Figure 36. North America Molecular Blood Revenue Market Share by Countries in 2019
Figure 37. USA Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 38. Canada Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 40. Europe Molecular Blood Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Molecular Blood Revenue Market Share by Countries in 2019
Figure 42. Germany Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 43. UK Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 44. France Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 45. Russia Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 46. Italy Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Molecular Blood Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Molecular Blood Revenue Market Share by Countries in 2019
Figure 49. China Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 50. Japan Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 51. Korea Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 52. India Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 54. South America Molecular Blood Revenue Market Share by Countries (2015-2020)
Figure 55. South America Molecular Blood Revenue Market Share by Countries in 2019
Figure 56. Brazil Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Molecular Blood Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Molecular Blood Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 61. UAE Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Molecular Blood Revenue and Growth Rate (2015-2020)
Figure 64. Global Molecular Blood Revenue Share by Type (2015-2020)
Figure 65. Global Molecular Blood Revenue Share by Type in 2019
Figure 66. Global Molecular Blood Market Share Forecast by Type (2021-2025)
Figure 67. Global PCR Revenue Growth Rate (2015-2020)
Figure 68. Global PCR-RFLP Revenue Growth Rate (2015-2020)
Figure 69. Global AS-PCR or PCR-SSP Revenue Growth Rate (2015-2020)
Figure 70. Global Multiplex PCR Revenue Growth Rate (2015-2020)
Figure 71. Global Real Time PCR Revenue Growth Rate (2015-2020)
Figure 72. Global Sanger DNA Sequencing Revenue Growth Rate (2015-2020)
Figure 73. Global Pyrosequencing Revenue Growth Rate (2015-2020)
Figure 74. Global Molecular Blood Revenue Share by Application (2015-2020)
Figure 75. Global Molecular Blood Revenue Share by Application in 2019
Figure 76. Global Molecular Blood Market Share Forecast by Application (2021-2025)
Figure 77. Global Blood Centers Revenue Growth Rate (2015-2020)
Figure 78. Global Plasma Fractionation Facilities Revenue Growth Rate (2015-2020)
Figure 79. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 80. Global Commercial/Private Laboratories Revenue Growth Rate (2015-2020)
Figure 81. Global Military Blood Banks Revenue Growth Rate (2015-2020)
Figure 82. Global Molecular Blood Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Molecular Blood Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Molecular Blood Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Molecular Blood Revenue Market Forecast (2021-2025)
Figure 86. Europe Molecular Blood Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Molecular Blood Revenue Market Forecast (2021-2025)
Figure 88. South America Molecular Blood Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Molecular Blood Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
分子イメージング剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Molecular Imaging Agents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Molecular Imaging Ag…- 分子診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Molecular Diagnostics m…
- 分子診断及びNATの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics and NAT market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Molecular Diagn…
- 分子インフルエンザ検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Molecular Influenza Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 分子診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Molecular Diagnostic Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…